| MT | microtubule |
| MAPs | MT-associated proteins |
| PTMs | post-translational modifications |
| MTOC | MT-organizing center |
| CFMO3 | congenital fibrosis of the extraocular muscles type 3 |
| DYT4 | torsion dystonia type4 |
| ALS | amyotrophic lateral sclerosis |
| K40 | lysine 40 |
| HDAC6 | histone deacetylase 6 |
| TTL | tubulin tyrosine ligase |
| CCP | cytoplasmic carboxypeptidases |
| TIP | end-tracking protein |
| FALS | familial amyotrophic lateral sclerosis |
| H-ABC | atrophy of the basal ganglia and cerebellum |
| MREI | tetrapeptide Met–Arg–Glu–Ile |
| AD | Alzheimer’s disease |
| CMT PD |
Charcot–Marie–Tooth disease Parkinson’s disease |
| αβ α-syn LRRK2 PrP |
β-amyloid α-synuclein leucine-rich repeat kinase 2 mouse prion protein |
| Epo D | epithilone D |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| TPD | triazolopyrimidines |
| NAP | davunetide |
| TSA | trichostatin |
| TubA | tubastatin A |